Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1978 1
1979 1
1980 1
1981 2
1983 1
1984 1
1985 1
1986 1
1988 1
1990 1
1991 2
1992 3
1993 5
1994 5
1995 4
1996 2
1997 5
1998 4
1999 6
2000 6
2001 3
2002 10
2003 9
2004 1
2005 1
2006 1
2007 2
2008 1
2009 1
2010 3
2011 1
2012 3
2013 3
2014 2
2015 3
2017 3
2018 4
2019 1
2020 1
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Results by year

Filters applied: . Clear all
Page 1
Premature Adrenarche.
Novello L, Speiser PW. Novello L, et al. Pediatr Ann. 2018 Jan 1;47(1):e7-e11. doi: 10.3928/19382359-20171214-04. Pediatr Ann. 2018. PMID: 29323690 Review.
In some instances, premature adrenarche may predict functional ovarian hyperandrogenism in adolescence. Management of premature adrenarche is largely aimed at observation, lifestyle adjustments for weight concerns, and monitoring for future possible persistent andro …
In some instances, premature adrenarche may predict functional ovarian hyperandrogenism in adolescence. Management of prematur …
Polycystic ovary syndrome.
Goudas VT, Dumesic DA. Goudas VT, et al. Endocrinol Metab Clin North Am. 1997 Dec;26(4):893-912. doi: 10.1016/s0889-8529(05)70286-3. Endocrinol Metab Clin North Am. 1997. PMID: 9429864 Review.
Underlying these clinical findings are several biochemical abnormalities, including LH hypersecretion, hyperandrogenism, acyclic estrogen production, decreased SHBG capacity, and hyperinsulinemia, all of which contribute to increased ovarian production of androgens, particularly …
Underlying these clinical findings are several biochemical abnormalities, including LH hypersecretion, hyperandrogenism, acyclic estrogen pr …
Hirsutism: Diagnosis and management.
Brodell LA, Mercurio MG. Brodell LA, et al. Gend Med. 2010 Apr;7(2):79-87. doi: 10.1016/j.genm.2010.04.002. Gend Med. 2010. PMID: 20435271 Review.
RESULTS: While there are many causes of hirsutism, the majority of patients have a benign process that may be idiopathic. In some circumstances, hirsutism is a sign of functional ovarian hyperandrogenism or congenital adrenal hyperplasia. Even more rarely, it is the …
RESULTS: While there are many causes of hirsutism, the majority of patients have a benign process that may be idiopathic. In some circumstan …
The Polycystic Ovary Morphology-Polycystic Ovary Syndrome Spectrum.
Rosenfield RL. Rosenfield RL. J Pediatr Adolesc Gynecol. 2015 Dec;28(6):412-9. doi: 10.1016/j.jpag.2014.07.016. Epub 2014 Aug 27. J Pediatr Adolesc Gynecol. 2015. PMID: 25840648 Free PMC article. Review.
Two-thirds of PCOS patients have functionally typical PCOS, with typical functional ovarian hyperandrogenism manifest as 17-hydroxyprogesterone hyper-responsiveness to gonadotropin stimulation. Most, but not all, of the remainder have atypical functional ovarian …
Two-thirds of PCOS patients have functionally typical PCOS, with typical functional ovarian hyperandrogenism manifest as 17-hy …
Hair loss in women.
Camacho-Martínez FM. Camacho-Martínez FM. Semin Cutan Med Surg. 2009 Mar;28(1):19-32. doi: 10.1016/j.sder.2009.01.001. Semin Cutan Med Surg. 2009. PMID: 19341939 Review.
Excess release of ovarian androgens (ovarian SAHA) and alopecia of ovarian hyperandrogenism is treated with ovarian suppression and antiandrogens. ...
Excess release of ovarian androgens (ovarian SAHA) and alopecia of ovarian hyperandrogenism is treated with ovarian suppressio …
Premature adrenarche--a common condition with variable presentation.
Utriainen P, Laakso S, Liimatta J, Jääskeläinen J, Voutilainen R. Utriainen P, et al. Horm Res Paediatr. 2015;83(4):221-31. doi: 10.1159/000369458. Epub 2015 Feb 7. Horm Res Paediatr. 2015. PMID: 25676474 Free article. Review.
PA has been linked with unfavorable metabolic features including hyperinsulinism, dyslipidemia, and later-appearing ovarian hyperandrogenism. Although this common condition is usually benign, PA children with additional risk factors including obesity should be follo …
PA has been linked with unfavorable metabolic features including hyperinsulinism, dyslipidemia, and later-appearing ovarian hypera …
Which origin for polycystic ovaries syndrome: Genetic, environmental or both?
Fenichel P, Rougier C, Hieronimus S, Chevalier N. Fenichel P, et al. Ann Endocrinol (Paris). 2017 Jul;78(3):176-185. doi: 10.1016/j.ando.2017.04.024. Epub 2017 Jun 9. Ann Endocrinol (Paris). 2017. PMID: 28606381 Review.
Polycystic ovaries syndrome (PCOS), the most common female endocrine disorder, affects 7-10% of women of childbearing age. It includes ovarian hyperandrogenism, impaired follicular maturation, anovulation and subfertility. ...
Polycystic ovaries syndrome (PCOS), the most common female endocrine disorder, affects 7-10% of women of childbearing age. It includes ov …
Definition and significance of polycystic ovaries.
Dewailly D. Dewailly D. Baillieres Clin Obstet Gynaecol. 1997 Jun;11(2):349-68. doi: 10.1016/s0950-3552(97)80041-7. Baillieres Clin Obstet Gynaecol. 1997. PMID: 9536215 Review.
Hormonally, PCOS has recently been defined by the GnRH agonist test as a functional abnormality in ovarian androgen synthesis. This functional ovarian hyperandrogenism seems closely linked to hyperinsulinism secondary to an insulin resistance. ...
Hormonally, PCOS has recently been defined by the GnRH agonist test as a functional abnormality in ovarian androgen synthesis. This function …
Certified testosterone immunoassays for hyperandrogenaemia.
Luque-Ramírez M, Jiménez-Mendiguchia L, García-Cano A, Fernández-Durán E, de Dios Rosa V, Nattero-Chávez L, Ortiz-Flores AE, Escobar-Morreale HF. Luque-Ramírez M, et al. Eur J Clin Invest. 2018 Dec;48(12):e13029. doi: 10.1111/eci.13029. Epub 2018 Oct 8. Eur J Clin Invest. 2018. PMID: 30229887
METHODS: We conducted a cross-sectional study including 263 consecutive adult premenopausal women presenting with functional ovarian hyperandrogenism-including polycystic ovary syndrome (PCOS)-and 73 nonhyperandrogenic female volunteers who served to define referenc …
METHODS: We conducted a cross-sectional study including 263 consecutive adult premenopausal women presenting with functional ovarian …
106 results